Draft Guidance for Industry; Reopening of the Comment Period: Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products

TitleDraft Guidance for Industry; Reopening of the Comment Period: Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products
ToC Doc Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products
Docket Number2021-26699
Type Notice
Subject Draft Guidance for Industry; Reopening of the Comment Period:
Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products
Publication Date2021-12-10
Last Updated Date 2021-12-09 08:15:16 -0500
Last Public Inspection2021-12-09
Filed At2021-12-09T08:45:00.000-05:00
PDF 2021-26699_PI.pdf (102422 bytes)
Download TXT / HTML / JSON
Number of Pages 4
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021